When thinking about the remarkable advancements in multiple myeloma treatment, CAR T-cell therapy generates immense excitement due to its potential to provide deep and enduring responses for patients. Dr. Nina Shah, Global Head of Multiple Myeloma Clinical Development and Strategy at AstraZeneca,
Checkpoint inhibitor therapies have revolutionized cancer treatment by enhancing the immune system's ability to target and destroy cancer cells. By boosting the immune response, these therapies have made significant strides in prolonging the lives of patients with various types of cancer.
In a groundbreaking development, scientists have devised an innovative method for evaluating the oxygen delivery effectiveness of red blood cells (RBCs) by analyzing their shape. This advancement holds the potential to significantly enhance practices in transplant and transfusion medicine, as well
Lung fibrosis, or pulmonary fibrosis, is a debilitating disease characterized by the excessive buildup of fibrillar collagen, leading to scarring in the lung tissue. This scarring makes lung tissues stiff and reduces their elasticity, resulting in severe breathing difficulties and decreased oxygen
In an unprecedented advancement in cancer treatment, a research team led by Professor Kwang-Hyun Cho from KAIST has developed a groundbreaking technology that targets colon cancer by transforming malignant cells into normal-like cells without killing them. Unlike traditional cancer therapies that
The field of prostate cancer treatment has seen significant advances with the introduction of novel therapies aimed at enhancing patient outcomes. One such promising advancement is the use of gozetotide for the accurate detection of PSMA-positive prostate cancer. This breakthrough is particularly